Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v6-EN
Language French English
Date Updated 2021-04-08 2021-04-01
Drug Identification Number 00725250 00725250
Brand name TEVA-DOXYCYCLINE TEVA-DOXYCYCLINE
Common or Proper name DOXYCYCLINE 100MG CAP DOXYCYCLINE 100MG CAP
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DOXYCYCLINE DOXYCYCLINE
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 200 200
ATC code J01AA J01AA
ATC description TETRACYCLINES TETRACYCLINES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-03-17 2021-03-17
Estimated end date 2021-04-30 2021-04-30
Actual end date 2021-04-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments